Back
Cimpress PLC 10K Form
Buy
60
CMPR
Cimpress PLC
Last Price:
80.40
Seasonality Move:
13.86%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2023-10-26 | 10Q | CMPR/Cimpress PLC Quarterly |
2023-04-27 | 10Q | CMPR/Cimpress PLC Quarterly |
2023-01-26 | 10Q | CMPR/Cimpress PLC Quarterly |
2022-10-27 | 10Q | CMPR/Cimpress PLC Quarterly |
2022-04-28 | 10Q | CMPR/Cimpress PLC Quarterly |
2022-01-27 | 10Q | CMPR/Cimpress PLC Quarterly |
Receive CMPR News And Ratings
See the #1 stock for the next 7 days that we like better than CMPR
CMPR Financial Statistics
Sales & Book Value
Annual Sales: | $3.29B |
---|---|
Cash Flow: | $-27.19M |
Price / Cash Flow: | 10.17 |
Annual Sales: | $-22.60 |
Price / Book: | 0 |
Profitability
EPS (TTM): | 5.76000 |
---|---|
Net Income (TTM): | $156.58M |
Gross Margin: | $1.6B |
Return on Equity: | 0% |
Return on Assets: | 8.4% |
Cimpress PLC Earnings Forecast
Key Cimpress PLC Financial Ratios
- The Gross Profit Margin over the past 24 years for CMPR is 48.51%.
- The Selling, General & Administrative Expenses for CMPR have been equal to 30.24% of Gross Profit Margin.
- The Research & Development expenses have been 9.78% of Revenue.
- The Interest Expense is 68.99% of Operating Income.
- The Net Earning history of CMPR is 5.28% of Total Revenues.
- Per Share Earnings over the last 24 years have been positive in 15 years.
Cimpress PLC Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Commercial Services & Supplies |
Sector: | Industrials |
Current Symbol: | CMPR |
CUSIP: | N20146 |
Website: | cimpress.com |
Debt
Debt-to-Equity Ratio: | -2.8 |
---|---|
Current Ratio: | 0.64 |
Quick Ratio: | 0.34 |
Price-to-Earnings
Trailing P/E Ratio: | 12.33 |
---|---|
Forward P/E Ratio: | 0 |
CMPR Technical Analysis vs Fundamental Analysis
Buy
60
Cimpress PLC (CMPR)
is a Buy
Is Cimpress PLC a Buy or a Sell?
-
Cimpress PLC stock is rated a Buy
The current Cimpress PLC [CMPR] share price is $81.34. The Score for CMPR is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.